Analystreport

Flexion Therapeutics Inc (NASDAQ: FLXN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.

Flexion Therapeutics, Inc.  (FLXN) 
Last flexion therapeutics, inc. earnings: 11/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.flexiontherapeutics.com